Relation Therapeutics has announced the formation of a multi-program, strategic alliance with Novartis with the aim of accelerating the development... Read more
Category: Uncategorized
Strategic Collaboration to Expand Cardiometabolic Pipeline
On December 9, 2025, a major pharmaceutical corporation based in New York announced it had entered into an exclusive global... Read more
Mirum Pharmaceuticals Expands Portfolio With Bluejay Therapeutics Acquisition
Transaction Overview and Terms Mirum Pharmaceuticals Inc., a specialty pharmaceutical company focused on rare diseases, has reached an agreement to... Read more
Viatris Exits Preferred Equity Stake in Biocon Biologics in Major Transaction
The global healthcare enterprise Viatris has executed definitive agreements for the divestiture of its entire convertible preferred equity holding in... Read more
Sandoz Finalizes Acquisition of Just-Evotec Biologics EU SAS, Reinforcing Biosimilars Leadership
(Basel, December 8, 2025) – Sandoz Group AG (SIX: SDZ/OTCQX: SDZNY), the global leader in affordable medicines, announced the successful... Read more
AstraZeneca’s Dual-Targeting CAR-T Shows Encouraging Efficacy
(ASH Congress) – AstraZeneca (AZ) announced positive clinical data for its leading cell therapy candidate, AZD0120 (formerly GC012F), for the... Read more
Crescent and Kelun-Biotech Execute Double Deal to Swap Cancer Asset Rights
The pharmaceutical companies Crescent Biopharma (US-based) and Kelun-Biotech (China-based) have announced a strategic partnership to exchange licensing rights for two... Read more
Trial Data Opens Door for Earlier Use of Lilly’s BTK Inhibitor
(ORLANDO) – At an American Society of Hematology (ASH) meeting, the pharmaceutical company Eli Lillypresented results from a critical head-to-head... Read more
Pharma Megamerger: Major Drug Company Unifies $5.5 Billion Biologics Subsidiary
A major pharmaceutical company has announced the successful completion of a plan to fully integrate its Biologics subsidiary, officially making... Read more









